THNR ETF
Amplify Weight Loss Drug & Treatment ETF
AUM$4M
TER0.59%
Holdings22

✓All holdings
✓Overlap Analysis
✓ETF Screener
✓Compare ETFs
Showing 10 of 22 holdings(as of Apr 30, 2026)Top 10 Weight: 70.64%
THNR ETF Top Holdings
THNR holdings top 10 positions. The top 10 holdings account for 70.6% of the fund, led by Novo-Nordisk A/S-Spons Adr at 14.5%, Eli Lilly & Co at 12.4%, Regeneron Pharmaceuticals, Inc. at 6.2%.
THNR portfolio concentration is relatively high, with the top 10 representing 70.6% of total assets. The largest sector exposure is Health Care at 79.6%.
THNR sector allocation provides a detailed breakdown. THNR overlap tool shows how holdings compare to other funds in your portfolio.